PuraPharm Corp Ltd
HKEX:1498
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PuraPharm Corp Ltd
HKEX:1498
|
HK |
|
Seed Co Ltd
TSE:7743
|
JP |
|
M
|
Mars Group Holdings Corp
TSE:6419
|
JP |
|
Etihad Atheeb Telecommunication Company SJSC
SAU:7040
|
SA |
|
CURO Group Holdings Corp
OTC:CUROQ
|
US |
|
I
|
iSoftStone Information Technology Group Co Ltd
SZSE:301236
|
CN |
|
K
|
Kuchai Development Bhd
KLSE:KUCHAI
|
MY |
|
Petroleo Brasileiro SA Petrobras
BOVESPA:PETR4
|
BR |
|
A
|
Access Group Holdings Co Ltd
TSE:7042
|
JP |
|
Invesco Mortgage Capital Inc
NYSE:IVR
|
US |
|
A
|
Alior Bank SA
WSE:ALR
|
PL |
|
Atp Ticari Bilgisayar Agi ve Elektrik Guc Kaynaklari Uretim Pazarlama ve Ticaret AS
IST:ATATP.E
|
TR |
PuraPharm Corp Ltd
PuraPharm Corp. Ltd. is an investment holding company, which engages in the research and development, production and sale of concentrated Chinese medicine granule (CCMG) products and Chinese healthcare products, as well as rendering of Chinese medical diagnostic services. The firm operates through five business segments. The China CCMG segment is mainly engaged in the production and sales of CCMG products in China. The Hong Kong CCMG segment is mainly engaged in the sales of CCMG products, excluding the sales through self-operated clinics in Hong Kong. The Chinese Healthcare Products segment is mainly engaged in the production and sales of healthcare products in Hong Kong and China. The Clinics segment is mainly engaged in the provision of Chinese medical diagnostic services and sales of CCMG products through self-operated clinics. The Plantation segment is mainly engaged in the plantation and trading of raw Chinese herbs, and the manufacture and sale of traditional Chinese medicine (TCM) decoction pieces.
PuraPharm Corp. Ltd. is an investment holding company, which engages in the research and development, production and sale of concentrated Chinese medicine granule (CCMG) products and Chinese healthcare products, as well as rendering of Chinese medical diagnostic services. The firm operates through five business segments. The China CCMG segment is mainly engaged in the production and sales of CCMG products in China. The Hong Kong CCMG segment is mainly engaged in the sales of CCMG products, excluding the sales through self-operated clinics in Hong Kong. The Chinese Healthcare Products segment is mainly engaged in the production and sales of healthcare products in Hong Kong and China. The Clinics segment is mainly engaged in the provision of Chinese medical diagnostic services and sales of CCMG products through self-operated clinics. The Plantation segment is mainly engaged in the plantation and trading of raw Chinese herbs, and the manufacture and sale of traditional Chinese medicine (TCM) decoction pieces.
